ATNM
AMEX · Biotechnology
Actinium Pharmaceuticals Inc
$1.01
+0.01 (+1.48%)
Open$0.99
Previous Close$1.00
Day High$1.02
Day Low$0.97
52W High$2.41
52W Low$1.02
Volume—
Avg Volume136.7K
Market Cap32.44M
P/E Ratio—
EPS$-1.32
SectorBiotechnology
Analyst Ratings
Strong Buy
11 analysts
Price Target
+3,475.2% upside
Current
$1.01
$1.01
Target
$36.11
$36.11
$23.47
$36.11 avg
$39.96
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 5.34M | 4.99M | 5.52M |
| Net Income | -1,194,048 | -1,193,914 | -1,096,791 |
| Profit Margin | -22.4% | -23.9% | -19.9% |
| EBITDA | -1,875,472 | -1,575,968 | -1,727,883 |
| Free Cash Flow | -941,082 | -691,464 | -912,603 |
| Rev Growth | +5.7% | +20.9% | +5.2% |
| Debt/Equity | 0.64 | 0.67 | 0.80 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $214.98 | -1.15% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.28 | +0.41% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $140.30 | +0.67% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $447.26 | +0.16% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $777.25 | +0.60% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.73 | -0.65% | 139.7 | 43.84B |